BrightOwl Loader Loading

Summary

A highly experienced regulatory affairs professional with pharmaceutical education (Pharm. D., MPH, French Inspectorate). Areas of expertise include GMO and Advanced Therapy Regulations (i.e. USA, Europe and International). Roles and responsibilities cover all aspects of drug registration: education and training of partners, regulatory strategy, negotiations with regulatory bodies, preclinical, clinical, CMC aspects of dossiers, price-reimbursement and advertising promotion.

Experiences

Current Experience

  • Executive Director Regulatory Affairs - EMEA
    Since April 2015

Past Experience

  • Director Regulatory Affairs
    January 2007 --- March 2015
    Strategize on Global (USA-EU-Canada-Rest of the World) GMO / Gene Therapy / Biotechnology products drug development/registration Ensure strategies are applied (coordinate activities) Manage a Regulatory Affairs Manager Set budgets and resources related to these activities Support Business Development as appropriate

  • Associate Director Regulatory Affairs
    January 2005 --- January 2007
    Management of the IV Therapy European Team (4 Regulatory Affairs Specialists) in order to ensure: • Manage the European IV Therapy portfolio (+/- 80 products) • Provide Regulatory input in the optimisation process of Baxter’s IV Therapy portfolio Participation to departmental changes and interfacing activites • Active involvement in working groups for setting processes, SOPs and training (i.e. Global Change Control, Company Core Data Sheet, Electronic Data Management Systems (Publishing, Archiving)) • Set contract agreements with consultants • Manage budgets (budget fees, EU-IVT dept., Six-Sigma working groups dedicated to optimizing/reducing costs related to Regulatory Processes)

  • Manager Regulatory Affairs (Global)
    January 2002 --- January 2005
    • Global Regulatory Leader for CellCept® - Immunosuppressive Agent preventing transplant rejection and new Auto Immune Diseases indications (Orphan Indications such as Myasthenia Gravis, Lupus). • Strategize on development of new products in a global regulatory environment (organize and lead meetings w/ FDA, EMEA, National Agencies) and deal with competitors. Products comprise New Chemical Entities in Pulmonary arena (Retinoid Derivative in Chronic Obstructive Pulmonary Disease – Immunomodulator (VCAM) for Asthma). Establish Global Development Plans (preclinical and clinical Phase I through IV).

  • Senior Regulatory Affairs Associate
    January 1997 --- July 2002
    Having worked in Cambridge (USA) for 2 yrs and EU HQ (Paris) for 3.5 yrs Supervision of two Regulatory Affairs Associates in order to ensure: Regulatory activities for Avonex™ • Ensure submission of new marketing applications to the EMEA (centralised procedure). • Ensure maintenance of Avonex™ on the EU market. Drug Development activities • Plan, coordinate, prepare and submit clinical trial applications in order to ensure appropriate clinical investigation of Avonex™ as defined by the product development program. • Participate in the Project Team and provide European regulatory strategy for the Avonex™ new development programs. Program management activities • Lead cross departments group for operational plans for market launch of two additional products.

  • Regulatory Affairs Associate France
    January 1995 --- January 1997
    Cover all regulatory activities related to contacts with French Health Authorities (AFSSAPS), Ensure the overview of transfer and integrity of the regulatory files; review and approval of promotional material subsequent to the merger between Duphar S.A. and Solvay Pharma S.A.

Knowledge

LinkedIn Assessment :
Clinical DevelopmentBiotechnologyRegulatory StrategyFDAImmunologyRegulatory affairsRegulatory submissionsINDRegulatory RequirementsoncologyClinical trialsLife SciencesGene therapygenetically modified organismGMOorphan drugSOPPharmaceuticsStrategyLifesciencesDrug DevelopmentClinical researchBiopharmaceuticals

Education

  • Masters Public Health in Health Law/Economics (Europe/USA) from Université Paris Sud (Paris XI) in 1995
  • Lieutenant in Blood Banking/Transfusion Medicine Residency Program from Centre de transfusion sanguine des armees (CTSA)/French Military Blood Transfusion Center - Clamart in 1994
  • Pharm D in Pharmacy from Université catholique de Louvain in 1993
  • in from Lycee a Bernay in 1988

Languages

BrightOwl Assessment:
Self Assessment:
French
Native
English
Full Proficiency
Spanish
Full Proficiency

Area / Region

Zurich, Switzerland

Others

Driving License
  • Yes